PROGNOSTIC VALUE OF DNA INDEX, S-PHASE FRACTION AND P53 PROTEIN ACCUMULATION AFTER SURGICAL RESECTION OF ESOPHAGEAL SQUAMOUS-CELL CARCINOMAS IN THAILAND

被引:18
作者
CHANVITAN, A
NEKARDA, H
CASSON, AG
机构
[1] TECH UNIV MUNICH, KLINIKUM RECHTS ISAR, DEPT SURG, W-8000 MUNICH, GERMANY
[2] UNIV TORONTO, MT SINAI HOSP, DIV THORAC SURG, TORONTO, ON, CANADA
关键词
D O I
10.1002/ijc.2910630314
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognostic value of cell nuclear DNA content, S-phase fraction and p53 protein accumulation in esophageal squamous-cell carcinomas was studied in a consecutive series of 80 patients from a high-incidence region of southern Thailand, who underwent esophagectomy between 1983 and 1993. Flow cytometry was used to determine tumor ploidy, DNA index and S-phase fraction, while p53 protein accumulation was evaluated immunohistochemically using the monoclonal anti-p53 antibody, CO7. Biomarkers were correlated with clinico-pathologic findings and survival by univariate and multivariate analysis. p53 protein was found in 40 tumors (50%), and was associated with significantly reduced overall survival. In patients with immunopositive tumors, depth of primary tumor invasion, lymphnode status, TNM stage and tumor grade were also significant prognostic factors. Additional predictors of reduced overall survival after esophagectomy, determined by flow cytometry, included S-phase fraction above 10%, aneuploidy (DNA index 1.2-1.8) and multiploidy (DNA index >2.2). This study further implicates p53 in the pathogenesis of esophageal squamous-cell carcinoma. Prognostic factors such as p53 protein, S-phase fraction and DNA index may be useful in stratifying patients for adjuvant therapies in future clinical trials of esophageal cancer. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:381 / 386
页数:6
相关论文
共 39 条
  • [1] ASSOCIATION OF P53 PROTEIN EXPRESSION WITH TUMOR-CELL PROLIFERATION RATE AND CLINICAL OUTCOME IN NODE-NEGATIVE BREAST-CANCER
    ALLRED, DC
    CLARK, GM
    ELLEDGE, R
    FUQUA, SAW
    BROWN, RW
    CHAMNESS, GC
    OSBORNE, CK
    MCGUIRE, WL
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) : 200 - 206
  • [2] BENNETT WP, 1992, CANCER RES, V52, P6092
  • [3] BLOUNT PL, 1994, CANCER RES, V54, P2292
  • [4] Casson A G, 1995, Chest Surg Clin N Am, V5, P17
  • [5] CLINICAL IMPLICATIONS OF P53 GENE MUTATION IN THE PROGRESSION OF BARRETTS EPITHELIUM TO INVASIVE ESOPHAGEAL CANCER
    CASSON, AG
    MANOLOPOULOS, B
    TROSTER, M
    KERKVLIET, N
    OMALLEY, F
    INCULET, R
    FINLEY, R
    ROTH, JA
    [J]. AMERICAN JOURNAL OF SURGERY, 1994, 167 (01) : 52 - 57
  • [6] CASSON AG, 1991, CANCER RES, V51, P4495
  • [7] PROGNOSTIC VALUE OF P53 PROTEIN IN ESOPHAGEAL ADENOCARCINOMA
    CASSON, AG
    KERKVLIET, N
    OMALLEY, F
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1995, 60 (01) : 5 - 11
  • [8] CHANVITAN A, 1990, OESOPHAGEAL CANCER S, P81
  • [9] DOKI Y, 1993, CANCER, V72, P1813, DOI 10.1002/1097-0142(19930915)72:6<1813::AID-CNCR2820720604>3.0.CO
  • [10] 2-R